EXAS vs STEM · rev $2.76B vs rev $144.6M
EXACT Sciences Corporation (EXAS) versus Stem Inc (STEM) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Stem Inc (STEM) is a utilities - renewable company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported STEM revenue for 2024-12-31 was $144.6M. Net income was -$854.0M. Revenue was down 68.7% from 2023-12-31 to 2024-12-31. STEM currently screens at market cap $82.1M.
EXAS currently screens at market cap $20.03B. STEM currently screens at market cap $82.1M.
Not investment advice. Open the EXAS and STEM stock pages for the full models.
Not investment advice.